UBS lowered the firm’s price target on Baxter (BAX) to $24 from $35 and keeps a Neutral rating on the shares. The firm’s estimates reflect now reset expectations amid second half headwinds, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX: